Cytel Blog Dynamic Bayesian Borrowing to Bolster Limited Sample Sizes in Rare Indications

Evaluating the efficacy and safety of novel therapies in rare indications can be challenging due to the difficulty of recruiting enough patients to conduct a well-powered clinical trial. To address these challenges there has been growing interest in the use of